The burden of idiopathic pulmonary fibrosis: An unmet public health need

Respiratory Medicine

Volumn 108, Issue 7, 2014, Pages 955-967

  Lee, Augustine S ^a   Mira Avendano, Isabella ^a   Ryu, Jay H ^b   Daniels, Craig E ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Burden of illness; Comorbid illness; Epidemiology; Health related quality of life; Healthcare utilization; Idiopathic pulmonary fibrosis

Indexed keywords

ASPIRATION PNEUMONIA; CARDIOVASCULAR DISEASE; COMORBIDITY; COUGHING; DEPRESSION; DYSPNEA; EMPHYSEMA; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; LUNG CANCER; LUNG FIBROSIS; LUNG FUNCTION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; PULMONARY HYPERTENSION; QUALITY OF LIFE; REVIEW; SLEEP DISORDERED BREATHING; SOCIOECONOMICS; SURVIVAL RATE; COST OF ILLNESS; HEALTH CARE PLANNING; HEALTH SERVICE; IDIOPATHIC PULMONARY FIBROSIS; PROCEDURES; PUBLIC HEALTH SERVICE; STATISTICS AND NUMERICAL DATA; UTILIZATION;

COMORBIDITY; COST OF ILLNESS; HEALTH RESOURCES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; PALLIATIVE CARE; PUBLIC HEALTH ADMINISTRATION; QUALITY OF LIFE;

EID: 84902375258     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.03.015     Document Type: Review

References (146)

1. C. Vancheri, M. Failla, N. Crimi, and G. Raghu Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Eur Respir J 35 2010 496 504
2. G. Raghu, H.R. Collard, and J.J. Egan et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 2011 788 824
3. H.R. Collard, A.J. Ward, S. Lanes, D. Cortney Hayflinger, D.M. Rosenberg, and E. Hunsche Burden of illness in idiopathic pulmonary fibrosis J Med Econ 15 2012 829 835
4. A.L. Olson, J.J. Swigris, D.C. Lezotte, J.M. Norris, C.G. Wilson, and K.K. Brown Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003 Am J Respir Crit Care Med 176 2007 277 284
5. P.W. Noble, C. Albera, and W.Z. Bradford et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Lancet 377 2011 1760 1769
6. International Society for Heart and Lung Transplantation Heart/lung transplant registry 2013 Available at: http://www.ishlt.org/registries/slides. asp?slides=heartLungRegistry
7. C. Albera Challenges in idiopathic pulmonary fibrosis trials: the point on endpoints Eur Respir Rev 20 2011 195 200
8. D.M. Rose, and A.B. Montgomery Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 trials Am J Respir Crit Care Med 187 2013 1269
9. G. Raghu, H.R. Collard, and K.J. Anstrom et al. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 trials Am J Respir Crit Care Med 187 2013 1269
10. L. Nalysnyk, J. Cid-Ruzafa, P. Rotella, and D. Esser Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature Eur Respir Rev 21 2012 355 361
11. A. Fahim, M. Crooks, and S.P. Hart Gastroesophageal reflux and idiopathic pulmonary fibrosis: a review Pulm Med 2011 634613
12. C.J. Ryerson, J. Berkeley, V.L. Carrieri-Kohlman, S.Z. Pantilat, C.S. Landefeld, and H.R. Collard Depression and functional status are strongly associated with dyspnea in interstitial lung disease Chest 139 2011 609 616
13. K.O. Lindell, E. Olshansky, and M.K. Song et al. Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners Heart Lung 39 2010 304 313
14. S.D. Nathan, A. Basavaraj, and C. Reichner et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis Respir Med 104 2010 1035 1041
15. R.B. Hubbard, C. Smith, I. Le Jeune, J. Gribbin, and A.W. Fogarty The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study Am J Respir Crit Care Med 178 2008 1257 1261
16. V. Cottin, H. Nunes, and P.Y. Brillet et al. Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur Respir J 26 2005 586 593
17. D. Jastrzebski, J. Kozielski, and A. Banaś et al. Quality of life during one-year observation of patients with idiopathic pulmonary fibrosis awaiting lung transplantation J Physiol Pharmacol 56 Suppl. 4 2005 Sep 99 105
18. O. Nishiyama, H. Taniguchi, and Y. Kondoh et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med 99 2005 408 414
19. A.L. Olson, and J.J. Swigris Idiopathic pulmonary fibrosis: diagnosis and epidemiology Clin Chest Med 33 2012 41 50
20. G. Raghu, D. Weycker, J. Edelsberg, W.Z. Bradford, and G. Oster Incidence and prevalence of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 174 2006 810 816
21. E.R. Fernandez Perez, C.E. Daniels, and D.R. Schroeder et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study Chest 137 2010 129 137
22. S. Ohno, T. Nakaya, M. Bando, and Y. Sugiyama Idiopathic pulmonary fibrosis-results from a Japanese nationwide epidemiological survey using individual clinical records Respirology 13 2008 926 928
23. V. Navaratnam, K.M. Fleming, and J. West et al. The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax 66 2011 462 467
24. J. Gribbin, R.B. Hubbard, I. Le Jeune, C.J. Smith, J. West, and L.J. Tata Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Thorax 61 2006 980 985
25. American Thoracic Society/European respiratory Society international Multidisciplinary consensus classification of the idiopathic interstitial pneumonias. This joint statement of the American Thoracic Society (ATS), and the European respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2002 277 304
26. L.H. Lancaster, W.R. Mason, and J.A. Parnell et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis Chest 136 2009 772 778
27. A.G. Nicholson, T.V. Colby, R.M. du Bois, D.M. Hansell, and A.U. Wells The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis Am J Respir Crit Care Med 162 2000 2213 2217
28. R. Hubbard, I. Johnston, and J. Britton Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study Chest 113 1998 396 400
29. J.A. Bjoraker, J.H. Ryu, and M.K. Edwin et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 157 1998 199 203
30. D.M. Mannino, R.A. Etzel, and R.G. Parrish Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data Am J Respir Crit Care Med 153 1996 1548 1552
31. C.E. Daniels, E.S. Yi, and J.H. Ryu Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Eur Respir J 32 2008 170 174
32. R.J. Panos, R.L. Mortenson, S.A. Niccoli, and T.E. King Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment Am J Med 88 1990 396 404
33. J.W. Song, S.B. Hong, C.M. Lim, Y. Koh, and D.S. Kim Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Eur Respir J 37 2011 356 363
34. V. Simon-Blancal, O. Freynet, and H. Nunes et al. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors Respiration 83 2012 28 35
35. D.S. Kim, J.H. Park, B.K. Park, J.S. Lee, A.G. Nicholson, and T. Colby Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Eur Respir J 27 2006 143 150
36. F.J. Martinez, S. Safrin, and D. Weycker et al. The clinical course of patients with idiopathic pulmonary fibrosis Ann Intern Med 142 2005 963 967
37. H.R. Collard, B.B. Moore, and K.R. Flaherty et al. Acute exacerbations of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 176 2007 636 643
38. T.J. Corte, and A.U. Wells Diffuse alveolar damage in idiopathic pulmonary fibrosis: does aetiology matter? Respirology 15 2010 873 875
39. A.J. Rice, A.U. Wells, and D. Bouros et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study Am J Clin Pathol 119 2003 709 714
40. M. Akira, H. Hamada, and M. Sakatani et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis AJR Am J Roentgenol 168 1997 79 83
41. V. Ambrosini, A. Cancellieri, and M. Chilosi et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series Eur Respir J 22 2003 821 826
42. J.G. Parambil, J.L. Myers, and J.H. Ryu Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy Chest. 128 2005 3310 3315
43. J.S. Lee, J.W. Song, and P.J. Wolters et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis Eur Respir J 39 2012 352 358
44. D.S. Kim Acute exacerbation of idiopathic pulmonary fibrosis Clin Chest Med 33 2012 59 68
45. P.A. Wijnen, J.A. Verschakelen, A. Bast, O. Bekers, and M. Drent Diffuse alveolar hemorrhage in courmarin users: a fibrosing interstitial pneumonia trigger? Lung. 191 2013 53 59
46. S. Gaudry, F. Vincent, and A. Rabbat et al. Invasive mechanical ventilation in patients with fibrosing interstitial pneumonia J Thorac Cardiovasc Surg 147 1 2014 47 53
47. G. Saydain, A. Islam, B. Afessa, J.H. Ryu, J.P. Scott, and S.G. Peters Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit Am J Respir Crit Care Med 166 2002 839 842
48. V. Ambrosini, A. Cancellieri, and M. Chilosi et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series Eur Respir J 22 2003 821 826
49. S. Blivet, F. Philit, J.M. Sab, B. Langevin, M. Paret, C. Guérin, and D. Robert Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure Chest 120 2001 209 212
50. T. Fumeaux, C. Rothmeier, and P. Jolliet Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis Intensive Care Med 27 2001 1868 1874
51. F.M. Al-Hameed, and S. Sharma Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis Can Respir J 11 2004 117 122
52. C. Mollica, G. Paone, and V. Conti et al. Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis Respiration 79 2010 209 215
53. J.B. Stern, H. Mal, and O. Groussard et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure Chest 120 2001 213 219
54. J.J. Swigris, and D. Fairclough Patient-reported outcomes in idiopathic pulmonary fibrosis research Chest 142 2012 291 297
55. T.E. King Jr., K.K. Brown, and G. Raghu et al. BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 2011 92 99
56. M.K. Han, D.S. Bach, and P.G. Hagan et al. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction Chest 143 2013 1699 1708
57. T.E. King Jr., J. Behr, and K.K. Brown et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 177 2008 75 81
58. G. Raghu, T.E. King Jr., and J. Behr et al. Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1) Eur Respir J 35 2010 118 123
59. Idiopathic Pulmonary Fibrosis Clinical Research Network D.A. Zisman, M. Schwarz, K.J. Anstrom, H.R. Collard, K.R. Flaherty, and G.W. Hunninghake A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis N Engl J Med 363 2010 620 628
60. G. Raghu, K.K. Brown, and U. Costabel et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial Am J Respir Crit Care Med 178 2008 948 955
61. C.J. Ryerson, D. Donesky, S.Z. Pantilat, and H.R. Collard Dyspnea in idiopathic pulmonary fibrosis: a systematic review J Pain Symptom Manage 43 2012 771 782
62. G. Thabut, H. Mal, and O. Groussard et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis J Thorac Cardiosvasc Surg 126 2003 469 475
63. T.J. George, G.J. Arnaoukatis, and A.S. Shah Lung transplantation in idiopathic pulmonary fibrosis Arch Surg 146 2011 1204 1209
64. J.A. Chang, J.R. Curtis, D.L. Patrick, and G. Raghu Assessment of health-related quality of life in patients with interstitial lung disease Chest 116 5 1999 Nov 1175 1182
65. G. Verma, T. Marras, N. Chowdhury, and L. Singer Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis Can Respir J 18 2011 283 287
66. C.S. Zimmermann, C.R. Carvalho, and K.R. Silveira et al. Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients Braz J Med Biol Res 40 2007 179 187
67. J.J. Swigris, W.G. Kuschner, S.S. Jacobs, S.R. Wilson, and M.K. Gould Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review Thorax 60 2005 588 594
68. J.J. Swigris, A.L. Stewart, M.K. Gould, and S.R. Wilson Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives Health Qual Life Outcomes 3 2005 61
69. J.J. Swigris, S.R. Wilson, and K.E. Green et al. Development of the ATAQ-IPF: a tool to assess quality of life in IPF Health Qual Life Outcomes 8 2010 77
70. K. Archontogeorgis, P. Steiropoulos, A. Tzouvelekis, E. Nena, and D. Bouros Lung cancer and interstitial lung diseases: a systematic review Pulm Med 2012 2012 315918
71. J. Gribbin, R. Hubbard, and C. Smith Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis Respir Med 103 2009 927 931
72. D.A. Zisman, and S.M. Kawut Idiopathic pulmonary fibrosis: a shot through the heart? Am J Respir Crit Care Med 178 2008 1192 1193
73. S.D. Nathan, P.W. Noble, and R.M. Tuder Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots Am J Respir Crit Care Med 175 2007 875 880
74. A.F. Shorr, J.L. Wainright, C.S. Cors, C.J. Lettieri, and S.D. Nathan Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant Eur Respir J 30 2007 715 721
75. J. Park, D.S. Kim, and T.S. Shim et al. Lung cancer in patients with idiopathic pulmonary fibrosis Eur Respir J 17 2001 1216 1219
76. C.J. Lettieri, S.D. Nathan, S.D. Barnett, S. Ahmad, and A.F. Shorr Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis Chest 129 2006 746 752
77. H.F. Nadrous, P.A. Pelikka, and M.J. Krowka et al. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis Chest 128 6 Suppl. 2005 616S 617S
78. D.A. Zisman, A.S. Karlamangla, and D.J. Ross et al. High-resolution chest CT findings do not prediect the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis Chest 132 2007 773 779
79. L. Farkas, J. Gauldie, N.F. Voelkel, and M. Kolb Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors Am J Respir Cell Mol Biol 45 2011 1 15
80. M.C. Aubry, J.L. Myers, and W.W. Douglas et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis Mayo Clin Proc 77 2002 763 770
81. I. Le Jeune, J. Gribbin, J. West, C. Smith, P. Cullinan, and R. Hubbard The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK Respir Med 101 2007 2534 2540
82. Y. Mizushima, and M. Kobayashi Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis: a review of Japanese cases Chest 108 1995 1272 1277
83. A. Nagai, and L. Chiyotani Lung cancer in patients with idiopathic pulmonary fibrosis Tohoku J Exp Med 167 1992 231 237
84. Y. Ozawa, T. Suda, and T. Naito et al. Cumulative incidence of and predictive factors for lung cancer in IPF Respirology 14 2009 723 728
85. G. Raghu, F. Nyber, and G. Morgan The epidemiology of interstitial lung disease and its association with lung cancer Br J Cancer 91 Suppl. 2 2004 S3 S10
86. M. Turner-Warwick, M. Lebowitz, B. Burrows, and A. Johnson Cryptogenic fibrosing alveolitis and lung cancer Thorax 35 1980 496 499
87. R. Hubbard, A. Venn, S. Lewis, and J. Britton Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study Am J Respir Crit Care Med 161 2000 5 8
88. C.E. Daniels, and J.R. Jett Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 11 2005 431 437
89. A. Watanabe, M. Miyajima, and T. Mishina et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis Gen Thorac Cardiovasc Surg 61 2013 254 261
90. V. Cottin, and J.F. Cordier Combined pulmonary fibrosis and emphysema in connective tissue disease Curr Opin Pulm Med 18 2012 418 427
91. C.J. Ryerson, T. Hartman, and B.M. Elicker et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Chest 144 2013 234 240
92. J. Wiggins, B. Strickland, and M. Turner-Warwick Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment Respir Med 84 1990 365 369
93. N. Hiwatari, S. Shimura, and T. Takishima Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause Respiration 60 1993 354 358 Holland AE. Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options, Chron Respir Dis 2010;7(2):101-11
94. M.J. Doherty, M.G. Pearson, E.A. O'Grady, V. Pellegrini, and P.M. Calverley Cryptogenic fibrosing alveolitis with preserved lung volumes Thorax 52 1997 998 1002
95. M.D. Jankowich, and S.I.S. Rounds Combined pulmonary fibrosis and empysema syndrome Chest 141 2012 222 231
96. T. Akagi, T. Matsumoto, and T. Harada et al. Coexistant emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis Respir Med 103 2009 1209 1215
97. Y. Kitaguchi, K. Fujimoto, M. Hanaoka, S. Kawakami, T. Honda, and K. Kobo Clinical characteristics of combined pulmonary fibrosis and emphysema Respirology 15 2010 265 271
98. R.W. Tobin, C.E. Pope, and C.A. Pellegrini et al. Increased prevalence of gastroesophageal reflex in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 158 1998 1804 1808
99. C.D. Bandeira, A.S. Rubin, and P.F. Cardoso et al. Prevalence of gastroesophageal reflux disease in patients with idiopathic pulmonary fibrosis J Bras Pneumonol 35 2009 1182 1189
100. G. Salvioli, G. Belmonte, and V. Stanghelini et al. Gastro-oesophageal reflux and interstitial lung disease Dig Liver Dis 36 2006 879 884
101. E. Savarino, R. Carbone, and E. Marabotto et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients Eur Respir J 42 2013 1322 1331
102. J.S. Lee, J.H. Ryu, and B.M. Elicker et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 184 2011 1390 1394
103. S. Mukhopadhyay, and A.L. Katzenstein Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens Am J Surg Pathol 31 2007 752 759
104. M.E.P. De Carvalho, R.A. Kairalla, and V.L. Capelozzi et al. Centrilobular fibrosis: a novel histological pattern of idiopathic interstitial pneumonia Pathol Res Pract 198 2002 577 583
105. D.M. Hiestand, P. Britz, M. Goldman, and B. Phillips Prevalence of symptoms and risk of sleep apnea in the US population: results from the national sleep foundation sleep in America 2005 poll Chest 130 2006 780 786
106. J.M. Parish, and V.K. Somers Obstructive sleep apnea and cardiovascular stress Mayo Clin Proc 79 2004 1036 1046
107. A.N. Vgontzas, E.O. Bixler, and G.P. Chrousos Sleep apnea is a manifestation of the metabolic syndrome Sleep Med Rev 9 2005 211 224
108. A.J. Ing, M.C. Ngu, and A.B. Breslin Obstructive sleep apnea and gastroesophageal reflux Am J Med 106 Suppl. 4a 2000 120 125S
109. K. Rasche, and M. Orth Sleep and breathing in idiopathic pulmonary fibrosis J Physiol Pharmarcol 60 Suppl. 5 2009 13 14
110. A. Pihtili, Z. Bingol, E. Kiyan, C. Cuhadaroglu, H. Issever, and Z. Gulbaran Obstructive sleep apnea is common in patients with interstitial lung disease Sleep and Breathing 17 4 2013 1281 1288
111. C. Mermigkis, J. Chapman, and J. Golish et al. Sleep-related breathing disorders in patients with idiopathic pulmonary fibrosis Lung 185 2007 173 178
112. C. Mermigkis, E. Stagaki, and S. Tryfon et al. How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis Sleep Breath 14 2010 387 390
113. K. Aihara, T. Oga, and Y. Harada et al. Coparison of biomarkers of subclinical lung in obstructive sleep apnea Respir Med 105 2011 939 945
114. D.J. Lederer, S. Jeslic, R.C. Basner, A. Ishizaka, and J. Bhattacharya Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnea Eur Respir J 33 2009 793 796
115. K.O. Leslie Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis Arch Pathol Lab Med 136 2012 591 600
116. D.J. Lederer, S. Jelic, R.C. Basner, and J. Bhattacharya Is obstructive sleep apnea a cause of idiopathic pulmonary fibrosis Arch Pathol Lab Med 136 2012 470
117. I. Noth, K.J. Anstrom, and S.B. Calvert et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 186 2012 88 95
118. J.F. Xu, G.R. Washko, and K. Hakshira et al. Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation Am J Respir Crit Care Med 185 2012 547 556
119. J. De Vries, B.L. Kessels, and M. Drent Quality of life of idiopathic pulmonary fibrosis patients Eur Respir J 17 2001 954 961
120. M.D. Elfferich, J. De Vries, and M. Drent Type D or " distressed" personality in sarcoidosis and idiopathic pulmonary fibrosis Sarcoidosis Vasc Diffuse Lung Dis 28 2011 65 71
121. K.K. Brown Chronic cough due to chronic interstitial pulmonary disease: ACCP evidence-based clinical practice guidelines Chest 129 2006 180s 189s
122. A.L. Key, K. Holt, A. Hamilton, J.A. Smith, and J.E. Earis Objective cough frequency in idiopathic pulmonary fibrosis Cough 6 2010 4 10
123. O. Nishiyama, H. Taniguchi, and Y. Kondoh et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis Eur Respir J 36 2010 1067 1072
124. G. Schoenheit, I. Becattelli, and A.H. Cohen Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients Chron Respir Dis 8 2011 225 231
125. H.R. Collard, and S.Z. Pantilat Dyspnea in interstitial lung disease Curr Opin Support Palliat Care 2 2008 100 104
126. H.R. Collard, T.E. King Jr., B.B. Bartelson, J.S. Vourlekis, M.I. Schwarz, and K.K. Brown Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 16 2003 538 542
127. D.A. Schwartz, R.A. Helmers, and J.R. Galvin et al. Determinants of survival in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 149 2 Pt 1 1994 450 454
128. O. Nishiyama, H. Miyajima, and Y. Fukai et al. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia Respir Med 107 2013 1241 1246
129. K. Kenn, R. Gloecki, and J. Behr Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis - a review Respiration 86 2013 89 99
130. C.J. Ryerson, C. Cayou, and F. Topp et al. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study Respir Med 108 2014 203 210
131. J.M. Madison, and R.S. Irwin Chronic cough in adults with interstitial lung disease Curr Opin Pulm Med 11 2005 412 416
132. B.D. Hope-Gill, S. Hilldrup, C. Davies, R.P. Newton, and N.K. Harrison A study of the cough reflex in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 168 2003 995 1002
133. U.G. Lalloo, S. Lim, R. DuBois, P.J. Barnes, and K.F. Chung Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease Eur Respir J 11 1998 702 705
134. M. Turner-Warwick, B. Burrow, and A. Johnson Cryptogenic fibrosing alveolitis: clinical features and their influence on survival Thorax 35 1980 171 180
135. R.G. Crystal, J.D. Fulmer, W.C. Roberts, M.L. Moss, B.R. Line, and H.Y. Reynolds Idiopathic pulmonary fibrosis: clinical, histological, radiographic, physiological, scintigraphic, cytological and biochemical aspects Ann Intern Med 85 1976 769 788
136. C.J. Ryerson, M. Abbritti, B. Ley, B.M. Elicker, K.D. Jones, and H.R. Collard Cough predicts prognosis in idiopathic pulmonary fibrosis Respirology 16 2011 969 975
137. M.R. Horton, V. Santopietro, and L. Mathew et al. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis Ann Intern Med 157 2012 398 406
138. A.C. Theodore, C.H. Tseng, N. Li, R.M. Elashoff, and D.P. Tashkin Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease Chest 142 2012 614 621
139. A. Okazaki, N. Ohkura, M. Fujimura, N. Katayama, and K. Kasahara Effects of pirfenidone on increase cough reflex sensitivity in guinea pigs Pulm Pharmacol Ther 26 2013 603 608
140. A. Azuma, Y. Taguchi, and T. Ogura et al. Pirfenidone Clinical Study Group in Japan. Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment Respir Res 12 2011 143
141. J.J. Egan Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient Eur Respir Rev 20 2011 114 117
142. P.N. Lanken, P.B. Terry, and H.M. DeLisser et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses Am J Respir Crit Care Med 177 2008 912 927
143. J.S. Temel, J.A. Greer, and A. Muzikansky et al. Early palliative care for patients with metastatic non-small-cell lung cancer N Engl J Med 363 2010 733 742
144. N. Berkowitz, S. Gupta, and G. Silberman Estimates of the direct lifetime costs of treatment for metastatic breast cancer Value Health 3 2000 23 30
145. V. Navaratnam, A. Fogarty, R. Glendening, T. McKeever, and R.B. Hubbard The increasing secondary care burden of idiopathic pulmonary fibrosis: hospital admission trends in England from 1998 to 2010 Chest 143 2013 1078 1084
146. Coalition for Pulmonary Fibrosis, Pulmonary Fibrosis Foundation and American Thoracic Society Press Release Coalition for pulmonary fibrosis, pulmonary fibrosis foundation and American Thoracic Society Announce new research grants for pulmonary fibrosis research Feb. 23, 2011. Available at: http://www.prnewswire.com/news-releases/coalition-for-pulmonary-fibrosis- pulmonary-fibrosis-foundation-and-american-thoracic-society-announce-new- research-grants-for-pulmonary-fibrosis-research-116735819.html